Dr Das on Updated Data Supporting the Use of Chemoimmunotherapy Regimens in ES-SCLC
Devika Das, MD, MSHQS,discusses updated data on the use of immunotherapy and platinum-based chemotherapy regimens in extensive-stage small cell lung cancer.
Stay updated with breaking news from Devika Das. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Devika Das, MD, MSHQS,discusses updated data on the use of immunotherapy and platinum-based chemotherapy regimens in extensive-stage small cell lung cancer.
/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to announce the appointment of a select group of volunteers to its newly formed Education...
While we are at home amid the second wave of the pandemic, the readers should not miss their favourite books.
E-Mail DURHAM, N.C. - A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease. Researchers at Duke Cancer Institute enrolled 50 Black and 50 white men with advanced prostate cancer to test whether there were outcome differences on treatment with the hormone therapy abiraterone acetate plus the steroid prednisone. In retrospective data reviews, the Duke researchers had previously ...
With new funding from the Veterans Affairs VA Lung Precision Oncology Program, Winship Cancer Institute of Emory University (Winship) will provide thoracic oncology expertise to help three VA medical centers expand access to high quality, disease altering lung cancer clinical trials to veterans in the Southeast. This five-year project is supported by $5 million in funding. It involves six investigators from three VA medical centers and their cancer centers partners. They are: Charleston/MUSC Hollings Cancer Center (Nichole Tanner, MD, MSCR; John Wrangle, MD), Birmingham/O’Neal Comprehensiv...